SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 103 filers reported holding SCICLONE PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 1.45 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $467,000 | +1.7% | 41,717 | 0.0% | 0.00% | – |
| Q2 2017 | $459,000 | +12.2% | 41,717 | 0.0% | 0.00% | – |
| Q1 2017 | $409,000 | -9.3% | 41,717 | 0.0% | 0.00% | – |
| Q4 2016 | $451,000 | +3.7% | 41,717 | -1.6% | 0.00% | – |
| Q3 2016 | $435,000 | -18.8% | 42,407 | +3.4% | 0.00% | -100.0% |
| Q2 2016 | $536,000 | +128.1% | 41,007 | +91.6% | 0.00% | – |
| Q1 2016 | $235,000 | -45.2% | 21,397 | -51.0% | 0.00% | – |
| Q2 2015 | $429,000 | -77.4% | 43,707 | -79.6% | 0.00% | -100.0% |
| Q1 2015 | $1,901,000 | +79.7% | 214,463 | +77.7% | 0.00% | +100.0% |
| Q4 2014 | $1,058,000 | +65.3% | 120,695 | +29.9% | 0.00% | 0.0% |
| Q3 2014 | $640,000 | +15.9% | 92,934 | -11.5% | 0.00% | 0.0% |
| Q2 2014 | $552,000 | -36.3% | 105,054 | -44.9% | 0.00% | 0.0% |
| Q1 2014 | $867,000 | +45.5% | 190,658 | +61.1% | 0.00% | 0.0% |
| Q4 2013 | $596,000 | +927.6% | 118,329 | +920.6% | 0.00% | – |
| Q2 2013 | $58,000 | – | 11,594 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|